LivaNova and MicroPort Scientific Corp today announced the sale of LivaNova’s Cardiac Rhythm Management Business Franchise to MicroPort for $190 million in cash.
LivaNova and MicroPort Scientific Corp today announced the sale of LivaNova’s Cardiac Rhythm Management Business Franchise to MicroPort for $190 million in cash.